TerminatedPhase 1

Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer

Stopped: Lack of funding

United States1 participantsStarted 2011-06

Plain-language summary

This pilot clinical trial studies beta-tricalcium phosphate bone graft in treating patients undergoing surgery for metastatic spine cancer. A bone graft may help healing and bone growth in patients undergoing surgery for spine cancer

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients undergoing surgery for spinal decompression for tatic spine cancer who require bone substitute for a posterolateral spinal fusion * Patients may or may not have posterolateral instrumentation Exclusion Criteria: * Status-post previous fusion with allogeneic bone graft

What they're measuring

Achievement of durable posterolateral fusion

Timeframe: Within 12 months

Trial details

NCT IDNCT01407341

SponsorUniversity of Southern California

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-07

View on ClinicalTrials.gov More Adult Spinal Cord Neoplasm trials